Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07489118 · ClinicalTrials.gov registry record · NA

Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health

A NA study of Metabolic Health and Food Acceptance, sponsored by North Carolina State University.

Active
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT07489118: Active NA study of Metabolic Health and Food Acceptance, sponsored by North Carolina State University.

NCT07489118 is a NA study of Metabolic Health and Food Acceptance that is active but no longer recruiting, run by North Carolina State University. The registered enrollment target is 72 participants, below the 50,138-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07489118, a NA study of Metabolic Health and Food Acceptance, is active but no longer recruiting, sponsored by North Carolina State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if pulse (pea) protein works similar to animal (whey) protein in protein bars consumed by healthy adults. The main questions it aims to answer are: What are the differences in taste and tolerance profiles between pea and whey proteins? What metabolic and immune changes do participants experience while eating them? What gastrointestinal microbiome shifts can be observed in these participants? How incorporation and complexation of polyphenols with these proteins changes the study outcomes? Participants will: Consume 1 protein bar with whey protein, pea protein, pea protein with complexed polyphenols, or pea protein with free polyphenols every day for 2 months. Visit the study site at baseline and end of study for checkups and tests. Fill dietary, food acceptance, gastrointestinal tolerance, and global health questionnaires.

Primary Outcome

Participants will report taste of the protein bars using a 9-point hedonic scale scored from 1 (dislike extremely) to 9 (like extremely) in a Food Acceptance Questionnaire (FAQ)

Interventions

  • OTHER Whey protein bar
  • OTHER Pea protein bar
  • OTHER Pea protein with complexed polyphenols bar
  • OTHER Pea protein with free polyphenols bar

Study Locations (1)

North Carolina

  • Plants for Human Health Institute - Kannapolis

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2025-05-01
Est. Completion 2026-04-01
Phase NA
North Carolina State University

19 total trials

What the registry record for NCT07489118 still lists

NCT07489118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 50,138-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Metabolic Health appearing as the primary indexed condition, and to 4 interventions - of which Whey protein bar is the first listed.

NCT07489118 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07489118 about?

NCT07489118 is a clinical study titled "Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health". The goal of this clinical trial is to learn if pulse (pea) protein works similar to animal (whey) protein in protein bars consumed by healthy adults. The main questions it aims to answer are: What are the differences in taste and tolerance profiles between pea and whey proteins? What metabolic and ...

What is the current status of trial NCT07489118?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-05-01. Estimated completion is 2026-04-01.

What conditions does trial NCT07489118 study?

This clinical trial studies the following conditions: Metabolic Health, Food Acceptance, Microbiome Composition, Immune Cells Activity.

What interventions are being tested in trial NCT07489118?

The interventions under investigation include: Whey protein bar (OTHER), Pea protein bar (OTHER), Pea protein with complexed polyphenols bar (OTHER), Pea protein with free polyphenols bar (OTHER).

Who is sponsoring clinical trial NCT07489118?

This trial is sponsored by North Carolina State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07489118 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07489118's enrollment target sits among peer trials

72 5th of 10 higher than 6 of 10 other Metabolic Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Metabolic Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07489118, the US trial registry maintained by the National Library of Medicine. NCT07489118 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.